Marinus Pharmaceuticals | 8-K: Current report
Marinus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Braunstein Scott
Marinus Pharmaceuticals | 10-K: Annual report
Marinus Pharmaceuticals | 8-K: Marinus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
Marinus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer MANNING MARTHA E
Marinus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Shafer Christina
Marinus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Hulihan Joseph
Marinus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Pfanstiel Steven
Marinus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Braunstein Scott
Marinus Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-LION POINT CAPITAL, LP(3.9%),LION POINT HOLDINGS GP, LLC(3.9%), etc.
Marinus Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Cormorant Global Healthcare Master Fund, LP(5.96%),Cormorant Global Healthcare GP, LLC(5.96%), etc.
Marinus Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Eventide Asset Management, LLC(8.30%),Finny Kuruvilla, M.D. Ph. D.(8.30%), etc.
Marinus Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Point72 Asset Management, L.P.(0.9%),Point72 Capital Advisors, Inc.(0.9%), etc.
Marinus Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Avoro Capital Advisors LLC(5.8%),Behzad Aghazadeh(5.8%)
Marinus Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Suvretta Capital Management, LLC(9.99%),Aaron Cowen(9.99%), etc.
Marinus Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals
Marinus Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Jennison Associates LLC(5.4%)
Marinus Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Adage Capital Partners, L.P.(4.73%),Adage Capital Partners GP, L.L.C.(4.73%), etc.
Marinus Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Franklin Resources, Inc.(7.0%),Franklin Advisers, Inc.(7.0%)
Marinus Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(8.4%)
No Data